Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Net Cash Flow (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Net Cash Flow for 17 consecutive years, with $7.4 million as the latest value for Q1 2026.

  • Quarterly Net Cash Flow rose 2679.25% to $7.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$26.0 million through Mar 2026, down 281.44% year-over-year, with the annual reading at $8.1 million for FY2025, 388.27% up from the prior year.
  • Net Cash Flow for Q1 2026 was $7.4 million at Achieve Life Sciences, up from -$11.0 million in the prior quarter.
  • The five-year high for Net Cash Flow was $50.8 million in Q1 2024, with the low at -$20.0 million in Q3 2025.
  • Average Net Cash Flow over 5 years is -$555000.0, with a median of -$5.1 million recorded in 2024.
  • The sharpest move saw Net Cash Flow crashed 443.55% in 2025, then soared 2679.25% in 2026.
  • Achieve Life Sciences' Net Cash Flow stood at $6.6 million in 2022, then tumbled by 166.51% to -$4.4 million in 2023, then surged by 173.46% to $3.2 million in 2024, then crashed by 443.55% to -$11.0 million in 2025, then surged by 166.78% to $7.4 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Net Cash Flow are $7.4 million (Q1 2026), -$11.0 million (Q4 2025), and -$20.0 million (Q3 2025).